Overview
Dr. Wang earned his medical degree at Vanderbilt University and a PhD in Cellular and Molecular Medicine from the Johns Hopkins University. In addition, he completed a residency in internal medicine at the Johns Hopkins Hospital, where he also received advanced training through a research fellowship in cancer biology and a clinical fellowship in medical oncology. He also spent a year at the National Cancer Institute as a Howard Hughes Medical Institute-National Institutes of Health Research Scholar.Certified by the American Board of Internal Medicine, Dr. Wang joined the University of Michigan faculty in 2024. He previously was a faculty member at UT Southwestern Medical Center.The author of numerous research articles, book chapters, and invited lectures, Dr. Wang’s clinical and research interests focus on esophageal cancer, gastric cancer, and gastroesophageal junction cancer. His research lab is focused on understanding the role of aberrant developmental pathway signaling in esophageal cancer and precursor lesions. He serves on the National GI Clinical Trials Steering Committee for the U.S. Department of Veterans Affairs.
His clinical expertise encompasses Esophageal Cancer and Fibrosarcoma.
He is actively involved in clinical research, co-authoring 52 peer reviewed articles. Dr. Wang is currently accepting new patients.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
1500 E Medical Center Dr, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Wang has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rogel Cancer Center
Rashmi Chugh is an Oncologist and a Hematologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology. Dr. Worden is currently accepting new patients.
Rogel Cancer Center
Scott Schuetze is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Schuetze is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma. Dr. Schuetze is currently accepting new patients.
Frequently Asked Questions about Dr. David H. Wang
How do I make an appointment with Dr. David H. Wang?
You can book an appointment with Dr. David H. Wang by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. David H. Wang a top-rated expert for Esophageal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. David H. Wang is classified as an Experienced expert for Esophageal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. David H. Wang specialize in?
While Dr. David H. Wang is a Oncology, they have specific expertise in Esophageal Cancer, Fibrosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. David H. Wang participate in research or clinical trials?
Yes. Dr. David H. Wang has published 52 articles and abstracts on conditions like Esophageal Cancer. You can view a list of Dr. David H. Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. David H. Wang accept my insurance?
Dr. David H. Wang accepts most major insurance plans, including Humana. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Esophageal CancerDr. Wang isExperienced. Learn about Esophageal Cancer.
- FibrosarcomaDr. Wang isExperienced. Learn about Fibrosarcoma.